Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts

• Egile Nagusiak: Špela Korat (Egilea), Natasha Shalina Rajani Bidesi (Egilea), Federica Bonanno (Egilea), Adriana Di Nanni (Egilea), Anh Nguyên Nhât Hoàng (Egilea), Kristina Herfert (Egilea), Andreas Maurer (Egilea), Umberto Maria Battisti (Egilea), Gregory David Bowden (Egilea), David Thonon (Egilea), Daniëlle Vugts (Egilea), Albert Dirk Windhorst (Egilea), Matthias Manfred Herth (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Neurodegenerative diseases such as Parkinson's disease (PD) are manifested by inclusion bodies of alpha-synuclein (α-syn) also called α-synucleinopathies. Detection of these inclusions is thus far only possible by histological examination of postmortem brain tissue. The possibility of non-invas...